Physicians news and physicians widget

Altus Pharmaceuticals Inc. (NASDAQ: ALTU) announced today that it is reaffirming its plan to submit a new drug application (NDA) for Trizytek TM (liprotamase) in the first-half of 2009.

Certain drugs used in premature babies and in pregnant women at risk for preterm deliveries kill brain cells, new animal studies ...

Celprogen Inc., a Global leader in the Stem Cell Research and Therapeutics industry for development of stem cell technologies in regenerative medicine, today announced that they have successfully validated an in vivo model system for testing efficacy of cancer drugs and also novel drug candidates for Human Glioblastoma.

Latina women who prefer speaking Spanish are more likely than other ethnic groups to express regret or dissatisfaction with their breast cancer treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.

Two critical properties of cancer cells are their ability to divide without restraint and to spread away from the primary tumor to establish new tumor sites.

Primary care doctors are an endangered breed of physician, a new survey suggests. The shortage could grow more critical, given ...

Renal Support Network, a national non-profit organization for people with chronic kidney disease (CKD), brought kidney community patient leaders together for a weekend meeting during the American Society of Nephrology's (ASN) Renal Week 2008 in Philadelphia this past week.

A new US study of nearly 6,000 women found that while regular exercise appeared to reduced their risk of cancer, this benefit was likely to be lost if they did not get enough sleep.

Medicare Part D prescription drug plan costs and coverage can change every year and 2009 is no exception. In 2009, Medicare beneficiaries can expect the possibility of higher monthly premiums, changes in the amount of initial deductibles, increases in the prescription drug co-payments, changes in prescription medication coverage and even possible re-assignment to another Medicare Part D plan.

Chronic Lymphocytic Leukemia (CLL) is a disease of the B lymphocytes of the immune system. Under normal conditions, B lymphocytes (or B cells) play an important role in battling infection. CLL is a disease manifested by uncontrolled growth of these B lymphocytes.